Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03011450 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
A Phase 3 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 471
- Enrollment target
NCT03011450 is a Phase 3 study that has completed, run by Kowa Research Institute. The registered enrollment target is 471 participants.
The verdict
NCT03011450, a Phase 3 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 471 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of K-877 in adult patients With Fasting High Triglyceride Levels ≥500 mg/dL and \<2000 mg/dL and Mild or Moderate Renal Impairment.
Interventions
- DRUG Fenofibrate
- DRUG K-877
- DRUG Placebo (for K-877)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2016-11-26 |
| Est. Completion | 2019-07-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03011450
The ClinicalTrials.gov registry entry for NCT03011450 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fenofibrate is the first listed.
NCT03011450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03011450 about?
NCT03011450 is a clinical study titled "Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment". The purpose of this study is to evaluate the efficacy and safety of K-877 in adult patients With Fasting High Triglyceride Levels ≥500 mg/dL and \<2000 mg/dL and Mild or Moderate Renal Impairment.
What is the current status of trial NCT03011450?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 471 participants. The study started on 2016-11-26. Estimated completion is 2019-07-05.
What interventions are being tested in trial NCT03011450?
The interventions under investigation include: Fenofibrate (DRUG), K-877 (DRUG), Placebo (for K-877) (DRUG).
Who is sponsoring clinical trial NCT03011450?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.